Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2797629 | 1.00 | SMN1; SMN2 (0.35) | SMN1; SMN2PTGDR2 | |
| SCHEMBL2327079 | 1.00 | SMN1; SMN2 (0.35) | SMN1; SMN2PTGDR2 | |
| SCHEMBL2323353 | 0.85 | F2 (0.32) | — | |
| SCHEMBL700951 | 0.85 | HDAC1 (0.39) | — | |
| SCHEMBL701747 | 0.85 | HDAC1 (0.39) | — | |
| SCHEMBL15619096 | 0.85 | HDAC1 (0.39) | — | |
| SCHEMBL2326461 | 0.83 | HSD17B10 (0.35) | SMN1; SMN2PTGDR2 | |
| SCHEMBL21261493 | 0.83 | CA1 (0.38) | SMN1; SMN2 | |
| SCHEMBL15922161 | 0.83 | HSD17B10 (0.35) | SMN1; SMN2PTGDR2 | |
| SCHEMBL2332745 | 0.83 | CA1 (0.38) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1852426-B1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE PPAR-ACTIVATING COMPOUND AND INTERMEDIATE OF THE SAME | KOWA CO (JP) | 2013-11-13 | — | — | EP | disclosed |
| US-7790903-B2 | Process for production of optically active PPAR-activating compound and intermediate of the same | KOWA CO., LTD. (JP) | 2010-09-07 | — | — | US | disclosed |
| US-7538242-B2 | Optically active PPAR-activating compound intermediate and method for producing same | KOWA CO., LTD. (JP) | 2009-05-26 | — | — | US | disclosed |
| US-20090023944-A1 | OPTICALLY ACTIVE PPAR-ACTIVATING COMPOUND INTERMEDIATE AND METHOD FOR PRODUCING SAME | KOWA CO., LTD. (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20080194833-A1 | Process For Production of Optically Active Ppar-Activating Compound and Intermediate of the Same | KOWA CO., LTD. (JP) | 2008-08-14 | — | — | US | disclosed |
| EP-1854779-A1 | OPTICALLY ACTIVE PPAR-ACTIVATING COMPOUND INTERMEDIATE AND METHOD FOR PRODUCING SAME | Kowa Company, Ltd. (JP) | 2007-11-14 | — | — | EP | disclosed |
| EP-1852426-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE PPAR-ACTIVATING COMPOUND AND INTERMEDIATE OF THE SAME | Kowa Company, Ltd. (JP) | 2007-11-07 | — | — | EP | disclosed |
| EP-1852426-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE PPAR-ACTIVATING COMPOUND AND INTERMEDIATE OF THE SAME | Kowa Company, Ltd. (JP) | 2007-11-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023944-A1 | OPTICALLY ACTIVE PPAR-ACTIVATING COMPOUND INTERMEDIATE AND METHOD FOR PRODUCING SAME | PPARA, PPARG, PPARD | SMN1; SMN2 4832/4885PTGDR2 694/4885 |
| US-20080194833-A1 | Process For Production of Optically Active Ppar-Activating Compound and Intermediate of the Same | PPARA, PPARG, PPARD | SMN1; SMN2 4842/4885PTGDR2 963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.